The Last Mile in Polio Eradication: Program Challenges and Perseverance
R Lopez Cavestany, M Eisenhawer, OM Diop, H Verma… - Pathogens, 2024 - mdpi.com
As the Global Polio Eradication Initiative (GPEI) strategizes towards the final steps of
eradication, routine immunization schedules evolve, and high-quality vaccination …
eradication, routine immunization schedules evolve, and high-quality vaccination …
Novel oral polio vaccine type 2 use for polio outbreak response: A global effort for a global health emergency
FD Kurji, AS Bandyopadhyay, S Zipursky, LV Cooper… - Pathogens, 2024 - mdpi.com
A sharp rise in circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks in the years
following the cessation of routine use of poliovirus type 2-containing oral polio vaccine and …
following the cessation of routine use of poliovirus type 2-containing oral polio vaccine and …
One billion doses and WHO prequalification of nOPV2: implications for the global polio situation and beyond
AS Bandyopadhyay, LV Cooper… - PLOS Global Public …, 2024 - journals.plos.org
With the COVID-19 pandemic abating, the only remaining Public Health Emergency of
International Concern is polio [1]. Remarkable progress has been made in reducing the …
International Concern is polio [1]. Remarkable progress has been made in reducing the …
Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in …
KM Thompson, DA Kalkowska, SE Kidd, CC Burns… - Vaccine, 2024 - Elsevier
Delays in achieving polio eradication have led to ongoing risks of poliovirus importations
that may cause outbreaks in polio-free countries. Because of the low, but non-zero risk of …
that may cause outbreaks in polio-free countries. Because of the low, but non-zero risk of …
Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020–2024
KM Thompson, K Badizadegan - Pathogens, 2024 - mdpi.com
Continued investment in the development and application of mathematical models of
poliovirus transmission, economics, and risks leads to their use in support of polio endgame …
poliovirus transmission, economics, and risks leads to their use in support of polio endgame …
Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance
RW Sutter, M Eisenhawer, NA Molodecky, H Verma… - Pathogens, 2024 - mdpi.com
Inactivated poliovirus vaccine (IPV), available since 1955, became the first vaccine to be
used to protect against poliomyelitis. While the immunogenicity of IPV to prevent paralytic …
used to protect against poliomyelitis. While the immunogenicity of IPV to prevent paralytic …
Nasal and pharyngeal mucosal immunity to poliovirus in children following routine immunization with inactivated polio vaccine (IPV) in the United States of America
A Godin, RI Connor, HN Degefu… - The Journal of …, 2024 - academic.oup.com
Abstract Background Although polioviruses (PVs) replicate in lymphoid tissue of both the
pharynx and ileum, research on polio vaccine-induced mucosal immunity has predominantly …
pharynx and ileum, research on polio vaccine-induced mucosal immunity has predominantly …
Polio Eradication: Status, Struggles and Strategies
AS Bandyopadhyay, RM Burke… - The Pediatric Infectious …, 2024 - journals.lww.com
Poliomyelitis is a potentially disabling, life-threatening and outbreak-prone disease caused
by infection by 1 of 3 different serotypes of poliovirus (type-1, type-2, or type-3). Polioviruses …
by infection by 1 of 3 different serotypes of poliovirus (type-1, type-2, or type-3). Polioviruses …